Medical Procedure News

RSS

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.

15 Feb 2010

TV medical dramas show inaccurate seizure management

Watching TV medical shows might not be the best way to learn what to do when someone has a seizure. Researchers screened the most popular medical dramas and found that doctors and nurses on the shows responded inappropriately to seizures almost half the time, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

15 Feb 2010

Members of interventional cardiology community wish former President Bill Clinton a quick recovery

Members of the interventional cardiology community wish former President Bill Clinton a quick recovery following his recent hospitalization for angioplasty and stenting.

15 Feb 2010

Discharged VAD implanted pediatric patient receives successful heart transplant after eight months

The wait is over for 16-year-old Francesco "Frank" De Santiago. On January 29, De Santiago received a donor heart in a nine-hour transplant operation at Texas Children's Heart Center De Santiago made news last October as the first child ever discharged from a pediatric hospital with an implanted mechanical heart pump, or ventricular assist device (VAD). Until then, pediatric patients with VADs remained in the hospital, often in ICU, while awaiting a donor heart.

15 Feb 2010

Fast method for producing bone and cartilage tissue using body's own cells

Injuries to joints and cartilage can have serious consequences, including osteoarthritis. Cartilage degeneration in joints is a widespread disease in Germany and worldwide. Prof. Dr. Prasad Shastri is an expert in tissue engineering (TE), tissue construction and tissue cultivation using the body's own cells. He is Professor of Biofunctional Macromolecular Chemistry at the Centre for Biological Signalling Studies (BIOSS), a Cluster of Excellence at the University of Freiburg, where he has been researching for the last year.

15 Feb 2010

Surgical outcomes for hip and knee replacement better at specialized hospitals

The more specialized a hospital is in orthopedic surgical care, the better the outcomes appear to be for patients undergoing hip and knee replacement surgery, University of Iowa researchers report in a new study of Medicare patients.

15 Feb 2010

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

CoAxia™, Inc. of Maple Grove, MN, announced today the completion of enrollment in its SENTIS randomized, controlled, pivotal trial of NeuroFlo™ Perfusion Augmentation Therapy as an acute interventional treatment for ischemic stroke. The Company plans to complete data collection and analysis of results in Q3 of 2010 and, if warranted, submit a PMA to the US FDA.

15 Feb 2010

Ragweed pollen allergy: SLIT safe and effective alternative to injections

An oral allergy treatment administered in drops under the tongue is a safe and effective alternative to injections for adults who are allergic to ragweed pollen, according to a study published today in the Journal of Allergy and Clinical Immunology by allergic disease specialist at Allegheny General Hospital.

15 Feb 2010

Adult stem cell transplant therapy may help prevent amputations from PAD

Grant Medical Center recently completed the nation's first published study of a new procedure that may give hope to millions of patients facing lower limb amputations from peripheral arterial disease (PAD). PAD is a painful circulatory problem in the legs that affects 10 million Americans. If left untreated, it can lead to serious complications such as stroke, amputation and death.

12 Feb 2010

President Bill Clinton undergoes stent insertion procedure: American Heart Association comments

Volunteers and staff of the American Heart Association extend their thoughts and well wishes to former President Bill Clinton upon the reports that he has undergone a procedure to insert stents to widen narrowed coronary arteries. President Clinton, who underwent quadruple coronary bypass surgery in 2004, partnered with the Association through his Foundation to jointly form the Alliance for a Healthier Generation to reduce the prevalence of childhood obesity in the United States.

12 Feb 2010

New pain management options for patients undergoing knee or hip replacements

Patients undergoing knee or hip replacements recover more quickly when treated with targeted pain-blocking medications that may eliminate the need for general anesthesia during surgery and intravenous narcotics drugs after surgery.

12 Feb 2010

MITA endorses eight key principles to reduce unnecessary radiation exposure and medical errors

The Medical Imaging & Technology Alliance (MITA), the leading association representing the manufacturers, innovators and developers of medical imaging and radiation therapy systems, today endorsed eight key principles to reduce exposure to unnecessary medical radiation, further minimize medical errors and improve reporting of adverse events.

12 Feb 2010

Study shows benefits of stent grafts over balloon angioplasty for patients who undergo dialysis

A randomized multicenter study of 190 patients at 13 medical centers shows-- for the first time-- the "superior" benefit of stent grafts over balloon angioplasty for maintaining function of dialysis access grafts in kidney failure patients who undergo dialysis. Until now, no other therapy has proven more effective than angioplasty.

12 Feb 2010

Better and standardized animal models needed for musculoskeletal regenerative medicine

Clinical testing and development of novel therapies based on advances in tissue engineering and regenerative medicine that will one day enable the repair and replacement of diseased or damaged human muscle, bone, tendons, and ligaments depends on the availability of good animal models.

12 Feb 2010

Center for Adolescent Bariatric Surgery performs 100th LAGB procedure

Few treatments are available to help obese adolescents who are unable to lose weight and are already suffering from obesity-related health problems. Laparoscopic adjustable gastric banding (LAGB), an option for adults in the United States since 2001, is showing promise for teens. The Center for Adolescent Bariatric Surgery, which opened at NewYork-Presbyterian Morgan Stanley Children's Hospital in 2006, recently performed its 100th LAGB procedure.

12 Feb 2010

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

Biologics, Inc., the leading cancer management company in the United States, announces that its Oncology Clinical Trial Services division has been selected by the National Marrow Donor Program® (NMDP), a nonprofit organization that facilitates unrelated hematopoietic cell transplants.

12 Feb 2010

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

RTI Biologics Inc., the Florida-based processor of orthopedic, dental, hernia and other biologic implants, has donated Matrix HD™ sterilized dermis allografts to use in limb salvage procedures for victims of the recent natural disasters in Haiti.

12 Feb 2010

NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer trial

NewLink Genetics Corporation announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for a pivotal Phase 3 trial of its HyperAcute immunotherapy in pancreatic cancer. Pancreatic cancer is highly lethal and is currently an area of very significant unmet medical need. The SPA is a written agreement between NewLink as the trial sponsor and the FDA regarding the design, endpoints, and planned statistical analysis of a Phase 3 trial to be used in support of a Biologic License Application (BLA).

12 Feb 2010

Quebec transplantation: 431 people receive 499 organs from 138 deceased donors

Owing to the generosity of Quebecers, 499 organs from 138 deceased donors in 2009 were transplanted into 431 recipients. Though there were 13 fewer donors than in 2008, Québec posted an average of more than 3.6 transplanted organs per deceased donor in 2009, placing the province among the leaders in Canada and even North America. "We're particularly proud of the sustained collaboration of professionals in hospitals in 2009," says Louis Beaulieu, chief executive officer of Québec-Transplant, the organization responsible for coordinating the organ donation process.

11 Feb 2010

Bard FLAIR Endovascular Stent Graft more effective than balloon angioplasty for failing dialysis grafts

C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.

11 Feb 2010

Medical Procedure News

Genous Bio-engineered R stent beneficial for patients not suitable for long term DAPT

TV medical dramas show inaccurate seizure management

Members of interventional cardiology community wish former President Bill Clinton a quick recovery

Discharged VAD implanted pediatric patient receives successful heart transplant after eight months

Fast method for producing bone and cartilage tissue using body's own cells

Surgical outcomes for hip and knee replacement better at specialized hospitals

CoAxia completes enrollment in NeuroFlo Perfusion Augmentation Therapy trial for ischemic stroke

Ragweed pollen allergy: SLIT safe and effective alternative to injections

Adult stem cell transplant therapy may help prevent amputations from PAD

President Bill Clinton undergoes stent insertion procedure: American Heart Association comments

New pain management options for patients undergoing knee or hip replacements

MITA endorses eight key principles to reduce unnecessary radiation exposure and medical errors

Study shows benefits of stent grafts over balloon angioplasty for patients who undergo dialysis

Better and standardized animal models needed for musculoskeletal regenerative medicine

Center for Adolescent Bariatric Surgery performs 100th LAGB procedure

NMDP Phase III filgrastim trial: Biologics to provide pharmacy management services

RTI Biologics supports Haiti relief efforts with Matrix HD sterilized dermis allografts donation

NewLink Genetics receives FDA SPA approval for HyperAcute immunotherapy Phase 3 pancreatic cancer trial

Quebec transplantation: 431 people receive 499 organs from 138 deceased donors

Bard FLAIR Endovascular Stent Graft more effective than balloon angioplasty for failing dialysis grafts

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News